Metabolic effects of growth hormone therapy in an Alstrom syndrome patient

被引:20
作者
Tai, TS
Lin, SY
Sheu, WHH
机构
[1] Taichung Vet Gen Hosp, Div Endocrinol & Metab, Dept Internal Med, Taichung 407, Taiwan
[2] Chia Yi Christian Hosp, Div Endocrinol & Metab, Chiayi, Taiwan
关键词
alstrom syndrome; growth hormone; insulin resistance; acanthosis nigricans;
D O I
10.1159/000074248
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: To investigate the metabolic effects of recombinant human growth hormone ( rhGH) in an Alstrom syndrome patient with growth hormone deficiency. Methods: A 15-year- old Alstrom syndrome boy with growth hormone deficiency received rhGH therapy for 1 year. Biochemical parameters, including hepatic enzyme levels, lipid profiles, and insulin sensitivity, were measured. Body composition analysis and computed tomography scans of the liver were performed. Results: After 1 year of rhGH treatment, body fat mass, fat infiltration in the liver, and serum lipid profiles had all decreased. Insulin sensitivity and acanthosis nigricans improved. Conclusion: rhGH therapy might have beneficial effects on body composition, liver fat content, lipid profiles, and insulin resistance in Alstrom syndrome patients, with improvement of the glucose homeostasis. Copyright (C) 2003 S. Karger AG, Basel.
引用
收藏
页码:297 / 301
页数:5
相关论文
共 33 条
[1]   Effects of four years' treatment with biosynthetic human growth hormone (GH) on glucose homeostasis, insulin secretion and lipid metabolism in GH-deficient adults [J].
Al-Shoumer, KAS ;
Gray, R ;
Anyaoku, V ;
Hughes, C ;
Beshyah, S ;
Richmond, W ;
Johnston, DG .
CLINICAL ENDOCRINOLOGY, 1998, 48 (06) :795-802
[2]  
AlShoumer KAS, 1996, EUR J ENDOCRINOL, V135, P559, DOI 10.1530/eje.0.1350559
[3]   GROWTH-HORMONE DEFICIENCY IN 2 SIBLINGS - WITH ALSTROM SYNDROME [J].
ALTER, CA ;
MOSHANG, T .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1993, 147 (01) :97-99
[4]   Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in prepubertal children with exogenous obesity: Effect of short- and long-term weight reduction [J].
Argente, J ;
Caballo, N ;
Barrios, V ;
Pozo, J ;
Munoz, MT ;
Chowen, JA ;
Hernandez, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (07) :2076-2083
[5]  
Awazu M, 1997, AM J MED GENET, V69, P13, DOI 10.1002/(SICI)1096-8628(19970303)69:1<13::AID-AJMG3>3.0.CO
[6]  
2-U
[7]   Mutations in ALMS1 cause obesity, type 2 diabetes and neurosensory degeneration in Alstrom syndrome [J].
Collin, GB ;
Marshall, JD ;
Ikeda, A ;
So, WV ;
Russell-Eggitt, I ;
Maffei, P ;
Beck, S ;
Boerkoel, CF ;
Sicolo, N ;
Martin, M ;
Nishina, PM ;
Naggert, JK .
NATURE GENETICS, 2002, 31 (01) :74-78
[8]   HEPATIC-DYSFUNCTION IN ALSTROM DISEASE [J].
CONNOLLY, MB ;
JAN, JE ;
COUCH, RM ;
WONG, LTK ;
DIMMICK, JE ;
RIGG, JM .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1991, 40 (04) :421-424
[9]   EXCESS INSULIN BINDING TO INSULIN-LIKE GROWTH-FACTOR RECEPTORS - PROPOSED MECHANISM FOR ACANTHOSIS NIGRICANS [J].
CRUZ, PD ;
HUD, JA .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1992, 98 (06) :S82-S85
[10]   An open 36-month study of lipid changes with growth hormone in adults: Lipid changes following replacement of growth hormone in adult acquired growth hormone deficiency [J].
Garry, P ;
Collins, P ;
Devlin, JG .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1996, 134 (01) :61-66